All News

Amir Ali, PharmD, BCOP highlights the success of shorter-treatment duration venetoclax in patients with acute myeloid leukemia and efficacy of pre-transplant blinatumomab in those with acute lymphocytic leukemia.

Rakesh Popat, MBBS, PhD explains the mechanisms of action behind the improvement in minimum residual disease in patients with lenalidomide-refractory multiple myeloma with cilta-cel compared with standard of care.

Jason Wang, MD highlights the reduction in incidence and severity of adverse events such as cytokine release syndrome and ICANS following axi-cel treatment in patients with R/R LBCL.

A ketogenic diet and its key metabolite, β-hydroxybutyrate, enhance the efficacy of CAR T-cell therapy by improving metabolic fitness, cytokine production, and cellular expansion, offering a promising, safe strategy for optimizing cancer immunotherapy.

Glucagon-like peptide 1 (GLP1) receptor agonists were shown to be associated with a reduced risk of venous thromboembolism (VTE), while high dietary fiber intake was shown to enhance microbiome health, lower graft-versus-host disease (GVHD) severity, and improve overall survival following allogeneic hematopoietic cell transplantation.

In newly diagnosed average and high standard risk B-cell acute lymphoblastic leukemia (B-ALL), blinatumomab improved disease-free survival (DFS) by approximately 97.5% and 94.1%, respectively.

Donald Moore discusses some of the obstacles that bispecific antibodies have faced in community cancer centers, including misconceptions coupled with a prevalent toxicity profile.

Jose Tinajero discusses how certain mutations can be indicators of blinatumomab treatment failure in patients with B-cell acute lymphoblastic leukemia.

Mazyar Shadman, MD, MPH, discusses the continued efficacy of zanubrutinib in patients with chronic lymphocytic leukemia.

As experts in medication management and health education, pharmacists can work with the administration to promote effective strategies that reduce misinformation and improve public health outcomes.

The US Department of Agriculture’s (USDA) guidance will help expedite H5N1 bird flu surveillance within the nation’s milk supply and dairy herds.

The addition of samidorphan can support the antipsychotic efficacy of olanzapine while mitigating associated weight gain.

The authors found high exposure to butylparaben and low exposure to 4-nonylphenol during pregnancy were risk factors for asthma development in children at 4 years of age.

Muvalaplin inhibits the formation of Lp(a) by blocking the initial interaction between apolipoprotein(a) and apo(b).

Durvalumab could offer further treatment for individuals with muscle-invasive bladder cancer.

Jerome Adams, former US surgeon general, discusses the importance of receiving recommended vaccines against influenza and COVID-19 for health care personnel.

Children born moderate to late preterm also showed more behavior difficulties compared with those born early term or later.

Pharmacists can educate and encourage screenings for colon cancer to ensure it is discovered as early as possible.

Pharmacists must make time for self-care and ensure a proper balance of work and life among their staff and themselves, according to National Association of Boards of Pharmacy Executive Director Al Carter.

Reduced hospital masking and testing policies increased rates of hospital-onset respiratory infections, including RSV.

During a 15-year period, 1 in 5 older adults living with COPD received a shingles vaccine.

Pelabresib is an investigational, oral, small molecule that inhibits bromodomain and extraterminal (BET) proteins.

Fabry disease is a rare lysosomal disorder that causes excessive deposition of lipids in tissues.

The data support the use of supportive anemia care agents in combination with ruxolitinib (Jakafi; Incyte Corp).

The authors suggest that targeted interventions to mitigate financial toxicity should be implemented to better support patients.

Zenocutuzumab-zbco is a bispecific antibody that targets and binds to HER2 and HER3.

The treatment is a type IA prodrug of dexamethasone that targets CD206+ macrophages.

The indication is for adults with limited-stage small cell lung cancer (LS-SCLC) whose disease has not progressed after platinum-based chemotherapy and radiation therapy.

Prevalence increased across all subgroups among children and adolescents, with decreases observed in young adults and elderly populations.

The management of MDS is primarily targeted at controlling or slowing the disease and preventing future complications as much as possible.